Interestingly, in vivo administration of the small molecule LX2343 improved cognitive deficits in a transgenic AD mouse model by inhibiting both JNK and BACE-1 activity, reducing Aβ production and promoting autophagy (Guo et al., 2016), though no direct anti-inflammatory mechanisms were investigated. This evidence concerns the gene MAPK8 and Alzheimer disease.